Innovations in Advanced Drug Delivery Systems: Overcoming Challenges for Personalized Medicine
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 34
Special Issue Editor
Interests: chalcones; natural products; antimicrobial activity; zebrafish; anxiolytic activity; spectroscopy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The pursuit of more effective therapies is constantly reshaping medicine. Traditional drug administration often suffers from poor bioavailability, systemic toxicity, and a lack of targeted delivery. Advanced drug delivery systems (ADDSs) offer a promising solution, but realizing their potential faces significant obstacles. Biological barriers pose a major challenge, requiring ADDS carriers like nanoparticles to navigate the bloodstream, evade the immune system, and cross cellular membranes. This necessitates precise engineering to optimize size, shape, surface charge, and targeting ligands for enhanced circulation, reduced off-target effects, and improved cellular uptake. Scalability is another hurdle, as laboratory-developed systems often prove difficult and costly to mass-produce consistently. Reproducibility, stability, long-term storage, and stringent regulatory requirements further complicate the manufacturing of ADDSs. Despite these challenges, ADDSs hold immense potential for personalized medicine.
We look forward to receiving your contributions.
Dr. Hélcio Silva Dos Santos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug administration
- polymers
- structural characterization
- nanoparticles
- in silico studies
- toxicity
- bioavailability
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
